Disease/Infection News

RSS

A call to action to share 2 billion doses of COVAX in 2021

Countries that are advanced in their vaccination programmes are seeing cases of COVID-19 decline, hospitalizations decrease and early signs of some kind of normality resume.

31 May 2021

B.1.617.2 variant of SARS-CoV-2 is partially resistant to antibody-mediated neutralization

A team of scientists from France has recently conducted a study to evaluate the sensitivity of the B.1.617 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to antibody-mediated neutralization.

31 May 2021

Reusing old vaccines to boost innate immunity against COVID-19

The COVID-19 vaccine is currently the best form of protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants. But a new perspective article published in the journal PNAS suggests it’s not the panacea to stopping SARS-CoV-2.

31 May 2021

WHO launches campaign to support people to quit smoking

The World Health Organization's 'Commit to Quit' tobacco campaign has made resources from its Quitting Toolkit freely available to more than a billion tobacco users, less than 5 months into the year-long campaign.

29 May 2021

New genetic editing tools could stop the spread of mosquito diseases

Since the onset of the CRISPR genetic editing revolution, scientists have been working to leverage the technology in the development of gene drives that target pathogen-spreading mosquitoes such as Anopheles and Aedes species, which spread malaria, dengue and other life-threatening diseases.

29 May 2021

Researchers assess the prognostic value of cardiac troponin I in COVID-19 patients

Corona Virus Disease (COVID -19) patients primarily appear with respiratory issues and viral pneumonia. The patients may also present cardiovascular issues includes early signs of acute myocardial injury.

29 May 2021

New drug effectively prevents severe COVID-19 in mice infected with SARS-CoV-2

The drug diABZI which activates the body's innate immune response -- was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2, according to scientists in the Perelman School of Medicine at the University of Pennsylvania

29 May 2021

New book provides insight into the pathophysiology of leprosy

Leprosy remains one of the biggest public health problems in many countries. It is a complex disease in several aspects, including clinical, histopathological, and molecular.

29 May 2021

Synbal and La Jolla Institute for Immunology collaborate to develop better COVID-19 models

The La Jolla Institute for Immunology (LJI) is partnering with Synbal, Inc., a preclinical biotechnology company based in San Diego, CA, to develop multi-gene, humanized mouse models for COVID-19 research. The research at LJI will be led by Professor Sujan Shresta, Ph.D., a member of the Institute's Center for Infectious Disease and Vaccine Research.

29 May 2021

AI technology can assess COVID-19 severity with a promising degree of accuracy

Artificial intelligence (AI) technology developed by researchers at the University of Waterloo is capable of assessing the severity of COVID-19 cases with a promising degree of accuracy.

29 May 2021

New biocompatible electrode prevents muscle loss in COVID-19 patients

A research group from Aarhus University has developed a special biocompatible electrode for electrical muscle stimulation that the group has integrated and 3D-printed onto medical support stockings.

29 May 2021

Africa has the highest death rates among critically ill COVID-19 patients, shows study

Africa has the highest death rates in the world among critically ill COVID-19 patients, with limited intensive care resources a major factor, a study says.

29 May 2021

Simple at-home taste test could predict duration and severity of SARS-CoV-2 symptoms

A JAMA Network Open research paper published today (26 May 2021) by Doctorpedia contributor Henry P. Barham, M.D correlating an association between the bitter taste receptor phenotype and clinical outcomes among patients with COVID-19 has confirmed that a simple at-home taste test could be a gamechanger in predicting duration and symptom severity of the virus.

29 May 2021

New, portable saliva screening test detects SARS-CoV-2 in five-minutes

International research led by Monash University and the Peter Doherty Institute for Infection and Immunity has achieved a proof of concept for a new, fast, portable saliva screening test that uses an infrared light technology to confirm infection with SARS-CoV-2.

29 May 2021

New LNP-based mRNA vaccine candidate protects against lethal SARS-CoV-2 in preclinical trials

A new study, published in Nano Letters, describes an effective new COVID-19 vaccine candidate based on a messenger ribonucleic acid (mRNA) platform.

28 May 2021

New SARS-CoV-2 lineages continue to threaten pandemic control in England, suggests genomic study

A new study shows the pattern of the rise of various strains in the UK, as shown by the data collected by the COVID-19 Genomics UK Consortium. This allows the rise and fall of 62 different viral lineages to be traced through over 300 local authorities from September 2020 to April 2021.

28 May 2021

Loss of gut epithelial barrier responsible for COVID-19-related MIS-C in children, suggests study

A new paper in the Journal of Clinical Investigation reports that this condition is due to damage to the gut, mediated by a decrease in the protein called zonulin, which is responsible for the integrity of the gut epithelial barrier. Reduced zonulin levels are found in several inflammatory and autoimmune conditions.

28 May 2021

Researcher investigates the behavior and life cycle of most infectious pathogenic bacteria

28 May 2021

Researchers identify a novel SARS-CoV-2 variant (with the V1230L mutation) in West Bengal, India

Researchers analyzed 2,000 viral genomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the causative agent of coronavirus disease 2019 (COVID-19) – sequences obtained from India and found a new variant that could be more infectious and transmissible.

28 May 2021

Glycosylation a significant element in SARS-CoV-2 infection and vaccine design, says study

A new study by researchers from Taiwan and the US suggests that the removal of unnecessary glycans from spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposes highly conserved sequences and opens the door for the development of broadly protective vaccines against the virus and its variants.

28 May 2021

Disease/Infection News

A call to action to share 2 billion doses of COVAX in 2021

B.1.617.2 variant of SARS-CoV-2 is partially resistant to antibody-mediated neutralization

Reusing old vaccines to boost innate immunity against COVID-19

WHO launches campaign to support people to quit smoking

New genetic editing tools could stop the spread of mosquito diseases

Researchers assess the prognostic value of cardiac troponin I in COVID-19 patients

New drug effectively prevents severe COVID-19 in mice infected with SARS-CoV-2

New book provides insight into the pathophysiology of leprosy

Synbal and La Jolla Institute for Immunology collaborate to develop better COVID-19 models

AI technology can assess COVID-19 severity with a promising degree of accuracy

New biocompatible electrode prevents muscle loss in COVID-19 patients

Africa has the highest death rates among critically ill COVID-19 patients, shows study

Simple at-home taste test could predict duration and severity of SARS-CoV-2 symptoms

New, portable saliva screening test detects SARS-CoV-2 in five-minutes

New LNP-based mRNA vaccine candidate protects against lethal SARS-CoV-2 in preclinical trials

New SARS-CoV-2 lineages continue to threaten pandemic control in England, suggests genomic study

Loss of gut epithelial barrier responsible for COVID-19-related MIS-C in children, suggests study

Researcher investigates the behavior and life cycle of most infectious pathogenic bacteria

Researchers identify a novel SARS-CoV-2 variant (with the V1230L mutation) in West Bengal, India

Glycosylation a significant element in SARS-CoV-2 infection and vaccine design, says study

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News